These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 25037221)
41. Coronary vessel development requires activation of the TrkB neurotrophin receptor by the Wilms' tumor transcription factor Wt1. Wagner N; Wagner KD; Theres H; Englert C; Schedl A; Scholz H Genes Dev; 2005 Nov; 19(21):2631-42. PubMed ID: 16264195 [TBL] [Abstract][Full Text] [Related]
42. Activation of vitamin D receptor by the Wilms' tumor gene product mediates apoptosis of renal cells. Wagner KD; Wagner N; Sukhatme VP; Scholz H J Am Soc Nephrol; 2001 Jun; 12(6):1188-1196. PubMed ID: 11373341 [TBL] [Abstract][Full Text] [Related]
43. The Wilms tumor suppressor-1 target gene podocalyxin is transcriptionally repressed by p53. Stanhope-Baker P; Kessler PM; Li W; Agarwal ML; Williams BR J Biol Chem; 2004 Aug; 279(32):33575-85. PubMed ID: 15155752 [TBL] [Abstract][Full Text] [Related]
44. Intermediate filament protein nestin is expressed in developing kidney and heart and might be regulated by the Wilms' tumor suppressor Wt1. Wagner N; Wagner KD; Scholz H; Kirschner KM; Schedl A Am J Physiol Regul Integr Comp Physiol; 2006 Sep; 291(3):R779-87. PubMed ID: 16614054 [TBL] [Abstract][Full Text] [Related]
45. Transcriptional regulation of the human Wilms' tumor gene (WT1). Cell type-specific enhancer and promiscuous promoter. Fraizer GC; Wu YJ; Hewitt SM; Maity T; Ton CC; Huff V; Saunders GF J Biol Chem; 1994 Mar; 269(12):8892-900. PubMed ID: 8132626 [TBL] [Abstract][Full Text] [Related]
46. Wilms' tumor suppressor gene (WT1) as a target gene of SRY function in a mouse ES cell line transfected with SRY. Toyooka Y; Tanaka SS; Hirota O; Tanaka S; Takagi N; Yamanouchi K; Tojo H; Tachi C Int J Dev Biol; 1998 Nov; 42(8):1143-51. PubMed ID: 9879712 [TBL] [Abstract][Full Text] [Related]
47. Expression of WT1 protein in fetal kidneys and Wilms tumors. Grubb GR; Yun K; Williams BR; Eccles MR; Reeve AE Lab Invest; 1994 Oct; 71(4):472-9. PubMed ID: 7967503 [TBL] [Abstract][Full Text] [Related]
48. GATA-1 and GATA-2 binding to 3' enhancer of WT1 gene is essential for its transcription in acute leukemia and solid tumor cell lines. Furuhata A; Murakami M; Ito H; Gao S; Yoshida K; Sobue S; Kikuchi R; Iwasaki T; Takagi A; Kojima T; Suzuki M; Abe A; Naoe T; Murate T Leukemia; 2009 Jul; 23(7):1270-7. PubMed ID: 19212333 [TBL] [Abstract][Full Text] [Related]
49. Repression of CMIP transcription by WT1 is relevant to podocyte health. Moktefi A; Zhang SY; Vachin P; Ory V; Henique C; Audard V; Rucker-Martin C; Gouadon E; Eccles M; Schedl A; Heidet L; Ollero M; Sahali D; Pawlak A Kidney Int; 2016 Dec; 90(6):1298-1311. PubMed ID: 27650733 [TBL] [Abstract][Full Text] [Related]
50. Transcriptional repression of the insulin-like growth factor I receptor (IGF-I-R) gene by the tumor suppressor WT1 involves binding to sequences both upstream and downstream of the IGF-I-R gene transcription start site. Werner H; Rauscher FJ; Sukhatme VP; Drummond IA; Roberts CT; LeRoith D J Biol Chem; 1994 Apr; 269(17):12577-82. PubMed ID: 8175666 [TBL] [Abstract][Full Text] [Related]
51. Analytical validation of a real-time reverse transcription-polymerase chain reaction quantitation of different transcripts of the Wilms' tumor suppressor gene (WT1). Dumur CI; Dechsukhum C; Wilkinson DS; Garrett CT; Ware JL; Ferreira-Gonzalez A Anal Biochem; 2002 Oct; 309(1):127-36. PubMed ID: 12381371 [TBL] [Abstract][Full Text] [Related]
52. Functional characterization of WT1 binding sites within the human vitamin D receptor gene promoter. Lee TH; Pelletier J Physiol Genomics; 2001 Dec; 7(2):187-200. PubMed ID: 11773605 [TBL] [Abstract][Full Text] [Related]
53. The human gene for diamine oxidase, an amiloride binding protein. Molecular cloning, sequencing, and characterization of the promoter. Chassande O; Renard S; Barbry P; Lazdunski M J Biol Chem; 1994 May; 269(20):14484-9. PubMed ID: 8182053 [TBL] [Abstract][Full Text] [Related]
54. WT1 promotes invasion of NSCLC via suppression of CDH1. Wu C; Zhu W; Qian J; He S; Wu C; Chen Y; Shu Y J Thorac Oncol; 2013 Sep; 8(9):1163-9. PubMed ID: 23945386 [TBL] [Abstract][Full Text] [Related]
55. WT1 targets Gas1 to maintain nephron progenitor cells by modulating FGF signals. Kann M; Bae E; Lenz MO; Li L; Trannguyen B; Schumacher VA; Taglienti ME; Bordeianou L; Hartwig S; Rinschen MM; Schermer B; Benzing T; Fan CM; Kreidberg JA Development; 2015 Apr; 142(7):1254-66. PubMed ID: 25804736 [TBL] [Abstract][Full Text] [Related]
56. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1. Zaia A; Fraizer GC; Piantanelli L; Saunders GF Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720 [TBL] [Abstract][Full Text] [Related]
57. Upregulation of Wilms' tumor gene 1 (WT1) in desmoid tumors. Amini Nik S; Hohenstein P; Jadidizadeh A; Van Dam K; Bastidas A; Berry RL; Patek CE; Van der Schueren B; Cassiman JJ; Tejpar S Int J Cancer; 2005 Mar; 114(2):202-8. PubMed ID: 15540161 [TBL] [Abstract][Full Text] [Related]
58. Sp1 is a critical regulator of the Wilms' tumor-1 gene. Cohen HT; Bossone SA; Zhu G; McDonald GA; Sukhatme VP J Biol Chem; 1997 Jan; 272(5):2901-13. PubMed ID: 9006935 [TBL] [Abstract][Full Text] [Related]
59. Expression of inhibin-alpha is regulated synergistically by Wilms' tumor gene 1 (Wt1) and steroidogenic factor-1 (Sf1) in sertoli cells. Ji SY; Hao JX; Li L; Zhang J; Zheng QS; Li XX; Wang XN; Han CS; Gao F; Liu YX PLoS One; 2013; 8(1):e53140. PubMed ID: 23326390 [TBL] [Abstract][Full Text] [Related]
60. The role of NF-kappaB in the regulation of the expression of wilms tumor suppressor gene WT1. Chen Y; Williams BR Gene Expr; 2000; 9(3):103-14. PubMed ID: 11243407 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]